The company has a definitive plan to fully acquire Wilson Wolf, a key partner in the high-growth cell and gene therapy market. This long-term M&A strategy signals a need for capital planning, integration roadmapping, and potential systems consolidation in the coming years.
Filing excerpt
We also completed a 19.9% investment in Wilson Wolf Corporation (“Wilson Wolf”) in fiscal 2023, and will acquire the remaining ownership in Wilson Wolf by the end of calendar year 2027, if not earlier due to its achievement of revenue or earnings before interest, taxes, depreciation, and amortization (“EBITDA”) targets.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Technologies
Vendors
sec-10kacquisitionAnnouncedGet every 10-K signal for Bio-Techne and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ca11a890-dcde-4c4a-9468-86ae1facf652 returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.
{
"signal_id": "ca11a890-dcde-4c4a-9468-86ae1facf652",
"signal_type": "sec-10k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-08-25T07:04:16.242+00:00",
"company": {
"name": "Bio-Techne",
"domain": "bio-techne.com"
},
"data": {
"detail": "The company has a definitive plan to fully acquire Wilson Wolf, a key partner in the high-growth cell and gene therapy market. This long-term M&A strategy signals a need for capital planning, integration roadmapping, and potential systems consolidation in the coming years.",
"metrics": {
"pct": 0.801,
"timeframe": "multi_year",
"pct_context": "remaining ownership of Wilson Wolf to be acquired"
},
"summary": "Bio-Techne to acquire remaining 80.1% of Wilson Wolf by end of 2027",
"excerpts": "We also completed a 19.9% investment in Wilson Wolf Corporation (“Wilson Wolf”) in fiscal 2023, and will acquire the remaining ownership in Wilson Wolf by the end of calendar year 2027, if not earlier due to its achievement of revenue or earnings before interest, taxes, depreciation, and amortization (“EBITDA”) targets.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926100322/tech-20260630x10k.htm",
"filing_date": "2026-08-24",
"filing_year": 2026,
"sales_relevance": "Integration needs coming",
"signal_category": "strategic",
"vendors_mentioned": [
"Wilson Wolf Corporation"
],
"technologies_mentioned": [
"cell and gene therapy",
"cell culture"
]
}
}
curl https://signals.autobound.ai/v1/signals/ca11a890-dcde-4c4a-9468-86ae1facf652 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bio-techne.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.